| Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma AT Parsa, JS Waldron, A Panner, CA Crane, IF Parney, JJ Barry, ... Nature medicine 13 (1), 84-88, 2007 | 1497 | 2007 |
| Liver stem cells and hepatocellular carcinoma L Mishra, T Banker, J Murray, S Byers, A Thenappan, AR He, K Shetty, ... Hepatology 49 (1), 318-329, 2009 | 406 | 2009 |
| Antibody-Based Immunotherapy of Cancer LM Weiner, JC Murray, CW Shuptrine Cell 148 (6), 1081-1084, 2012 | 363 | 2012 |
| PI (3) kinase is associated with a mechanism of immunoresistance in breast and prostate cancer CA Crane, A Panner, JC Murray, SP Wilson, H Xu, L Chen, JP Simko, ... Oncogene 28 (2), 306-312, 2009 | 213 | 2009 |
| Identification of cathepsin B as a mediator of neuronal death induced by Aβ-activated microglial cells using a functional genomics approach L Gan, S Ye, A Chu, K Anton, S Yi, VA Vincent, D Von Schack, D Chin, ... Journal of Biological Chemistry 279 (7), 5565-5572, 2004 | 164 | 2004 |
| Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer JE Reuss, V Anagnostou, TR Cottrell, KN Smith, F Verde, M Zahurak, ... Journal for immunotherapy of cancer 8 (2), 2020 | 133 | 2020 |
| Comprehensive regional and temporal gene expression profiling of the rat brain during the first 24 h after experimental stroke identifies dynamic ischemia‐induced gene … M Rickhag, T Wieloch, G Gidö, E Elmér, M Krogh, J Murray, S Lohr, ... Journal of neurochemistry 96 (1), 14-29, 2006 | 106 | 2006 |
| Association of STK11/LKB1 genomic alterations with lack of benefit from the addition of pembrolizumab to platinum doublet chemotherapy in non-squamous non-small cell lung cancer. F Skoulidis, KC Arbour, MD Hellmann, PD Patil, ME Marmarelis, ... Journal of Clinical Oncology 37 (15_suppl), 102-102, 2019 | 104 | 2019 |
| Antibody-Dependent Cellular Cytotoxicity (ADCC) VRG Román, JC Murray, LM Weiner Antibody Fc, 1-27, 2014 | 96 | 2014 |
| Automated pathway recognition system J Murray, D Hendrix, DJ Chin US Patent 6,876,930, 2005 | 69 | 2005 |
| Integrative tumor and immune cell multi-omic analyses predict response to immune checkpoint blockade in melanoma V Anagnostou, DC Bruhm, N Niknafs, JR White, XM Shao, JW Sidhom, ... Cell Reports Medicine 1 (8), 2020 | 55 | 2020 |
| A Mechanism of Resistance to Antibody-Targeted Immune Attack DS Aldeghaither, DJ Zahavi, JC Murray, EJ Fertig, GT Graham, YW Zhang, ... Cancer immunology research 7 (2), 230-243, 2019 | 52 | 2019 |
| Persistent mutation burden drives sustained anti-tumor immune responses N Niknafs, A Balan, C Cherry, K Hummelink, K Monkhorst, XM Shao, ... Nature medicine 29 (2), 440-449, 2023 | 50 | 2023 |
| Peripheral blood immune cell dynamics reflect antitumor immune responses and predict clinical response to immunotherapy M Hwang, JV Canzoniero, S Rosner, G Zhang, JR White, Z Belcaid, ... Journal for immunotherapy of cancer 10 (6), 2022 | 50 | 2022 |
| Heat shock protein 90α recruits FLIPS to the death-inducing signaling complex and contributes to TRAIL resistance in human glioma A Panner, JC Murray, MS Berger, RO Pieper Cancer research 67 (19), 9482-9489, 2007 | 50 | 2007 |
| Synthetic lethal screening reveals FGFR as one of the combinatorial targets to overcome resistance to Met-targeted therapy B Kim, S Wang, JM Lee, Y Jeong, T Ahn, DS Son, HW Park, H Yoo, ... Oncogene 34 (9), 1083-1093, 2015 | 37 | 2015 |
| Liquid biopsy approaches to capture tumor evolution and clinical outcomes during cancer immunotherapy L Sivapalan, JC Murray, JVL Canzoniero, B Landon, J Jackson, S Scott, ... Journal for immunotherapy of cancer 11 (1), 2023 | 36 | 2023 |
| Vaccine prevention of cancer: can endogenous antigens be targeted? LM Weiner, R Surana, J Murray Cancer Prevention Research 3 (4), 410-415, 2010 | 33 | 2010 |
| Acquisition of estrogen independence induces TOB1-related mechanisms supporting breast cancer cell proliferation YW Zhang, RE Nasto, R Varghese, SA Jablonski, IG Serebriiskii, ... Oncogene 35 (13), 1643-1656, 2016 | 32 | 2016 |
| Increased expression of the glioma-associated antigen ARF4L after loss of the tumor suppressor PTEN JH Chi, A Panner, K Cachola, CA Crane, J Murray, RO Pieper, CD James, ... Journal of neurosurgery 108 (2), 299-303, 2008 | 15 | 2008 |
Valsamo AnagnostouJohns Hopkins School of MedicineVerified email at jhmi.edu
